Xilio Therapeutics, Inc.XLONASDAQ
Loading
EV to Sales: Premium ValuationElevated
Percentile Rank100
Studio
Year-over-Year Change

Enterprise value to sales ratio

Latest
0.62
↑ 500% vs avg
Percentile
P100
Near historical high
Streak
1 yr
Consecutive growthElevated
Average
0.10
Historical baseline
PeriodValueYoY Change
20240.62-
20230.00-
20220.00-
20210.00-
20200.00-
20190.00-